NEW YORK, Aug. 27, 2017 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Weibo Corporation (NASDAQ:WB) from April 27, 2017 through June 22, 2017, inclusive (the “Class Period”) of the important August 28, 2017 lead plaintiff deadline in the first filed class action commenced by Rosen Law Firm. The lawsuit seeks to recover damages for Weibo investors under the federal securities laws.
To join the Weibo class action, go to http://www.rosenlegal.com/cases-1151.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, throughout the Class Period Defendants made false and/or misleading statements and/or failed to disclose that: (1) Weibo lacks a requisite internet audio/video program transmission license; (2) Weibo was posting certain commentary programs with content in violation of Chinese government regulations on its site; and (3) as a result, Defendants’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 28, 2017. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-1151.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Since 2014, Rosen Law Firm has been ranked #2 in the nation by Institutional Shareholder Services for the number of securities class action settlements annually obtained for investors. Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] [email protected] [email protected] www.rosenlegal.com


Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 



